RRM2 and liver cancer: Furthermore, the effects of RRM2 on elevating GSH were abolished when GSS was knocked out by CRISPR-Cas9 technology in both HepG2 and SMMC-7721 cells (Fig. 3l), demonstrating that GSS is a prerequisite for RRM2 to upregulate GSH in liver cancer cells.